Government to work with German firm CureVac on tackling potential mutations
The UK government has signed a deal for at least 50m doses of vaccines that could combat new variants of coronavirus, and is to work with the German manufacturer to help develop them.
The Department for Business, Energy and Industrial Strategy (BEIS) said it had struck the agreement with CureVac, which has already developed a first-generation vaccine that is undergoing large-scale clinical trials.
The government’s joint committee on vaccination and immunisation has published a list of groups of people who will be prioritised to receive a vaccine for Covid-19 in the UK. The list is:
Related: What are Covid variants – and should we be worried?
